This is a Validated Antibody Database (VAD) review about mouse Cdkn1a, based on 232 published articles (read how Labome selects the articles), using Cdkn1a antibody in all methods. It is aimed to help Labome visitors find the most suited Cdkn1a antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cdkn1a synonym: CAP20; CDKI; CIP1; Cdkn1; P21; SDI1; Waf1; mda6; p21Cip1; p21WAF

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (F-5)
  • immunohistochemistry knockout validation; human; 1:200; fig 5a
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in immunohistochemistry knockout validation on human samples at 1:200 (fig 5a). Genome Biol (2018) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-5)
  • western blot knockout validation; mouse; loading ...; fig 3d
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot knockout validation on mouse samples (fig 3d). Mol Pharmacol (2017) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-5)
  • western blot knockout validation; mouse; loading ...; fig 3h
In order to determine the role of p21 in regulating cardiac hypertrophic growth, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot knockout validation on mouse samples (fig 3h). Peptides (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-5)
  • western blot knockout validation; mouse; 1:1000
Santa Cruz Biotechnology Cdkn1a antibody (Santa, sc-6246) was used in western blot knockout validation on mouse samples at 1:1000. PLoS ONE (2015) ncbi
Abcam
domestic rabbit monoclonal (EPR18021)
  • western blot knockout validation; mouse; 1:500; loading ...; fig 1f
  • immunoprecipitation; mouse; loading ...; fig 6a
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3b
Abcam Cdkn1a antibody (Abcam, ab188224) was used in western blot knockout validation on mouse samples at 1:500 (fig 1f), in immunoprecipitation on mouse samples (fig 6a) and in immunohistochemistry on mouse samples at 1:500 (fig 3b). Cell Mol Gastroenterol Hepatol (2021) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-5)
  • western blot; human; 1:200; loading ...
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:200. Int J Mol Sci (2022) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:1000; loading ...; fig 5d, 5e
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:1000 (fig 5d, 5e). iScience (2022) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:1000; loading ...; fig 13
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:1000 (fig 13). Int J Oncol (2022) ncbi
mouse monoclonal (187)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 1j, 2g
  • immunohistochemistry - paraffin section; rat; 1:200; loading ...; fig 7d
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-817) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1j, 2g) and in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 7d). Int J Oral Sci (2022) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 6e, 6f
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples (fig 6e, 6f). Adv Sci (Weinh) (2022) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:3000; loading ...; fig 4d, 8k
  • western blot; mouse; 1:3000; loading ...; fig 4a, 7g
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:3000 (fig 4d, 8k) and in western blot on mouse samples at 1:3000 (fig 4a, 7g). Clin Transl Med (2021) ncbi
mouse monoclonal (F-5)
  • immunohistochemistry; human; fig s3i
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in immunohistochemistry on human samples (fig s3i). Nat Commun (2021) ncbi
mouse monoclonal (F-5)
  • western blot; rat; 1:200; loading ...; fig 5f
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, 6246) was used in western blot on rat samples at 1:200 (fig 5f). J Mol Med (Berl) (2021) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:1000; loading ...; fig 1b, 1e, 1h
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on mouse samples at 1:1000 (fig 1b, 1e, 1h). Proc Natl Acad Sci U S A (2021) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:400; fig 6f
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:400 (fig 6f). Int J Mol Sci (2021) ncbi
mouse monoclonal (F-5)
  • mass cytometry; mouse; loading ...; fig s3
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in mass cytometry on mouse samples (fig s3). EMBO J (2021) ncbi
mouse monoclonal (F-5)
  • immunohistochemistry - paraffin section; human; fig 6a
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in immunohistochemistry - paraffin section on human samples (fig 6a). Breast Cancer Res (2021) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 5m
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc6246) was used in western blot on human samples (fig 5m). J Exp Clin Cancer Res (2021) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:1000; loading ...
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on mouse samples at 1:1000. Exp Neurol (2021) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:200; loading ...; fig 2h
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on mouse samples at 1:200 (fig 2h). PLoS Genet (2020) ncbi
mouse monoclonal (187)
  • western blot; rat; loading ...; fig 5a
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-817) was used in western blot on rat samples (fig 5a). Mol Med Rep (2020) ncbi
mouse monoclonal (187)
  • western blot; human; loading ...; fig 3g
Santa Cruz Biotechnology Cdkn1a antibody (Santacruz Biotechnology, sc-817) was used in western blot on human samples (fig 3g). elife (2020) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:500; loading ...; fig 3e
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on mouse samples at 1:500 (fig 3e). EBioMedicine (2020) ncbi
mouse monoclonal (F-5)
  • western blot; rat; 1:200; loading ...; fig 5b
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on rat samples at 1:200 (fig 5b). Int J Nanomedicine (2020) ncbi
mouse monoclonal (F-5)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 3d
  • western blot; mouse; 1:1000; loading ...; fig 3a, 3b, 3c, s6c
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, SC-6246) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3d) and in western blot on mouse samples at 1:1000 (fig 3a, 3b, 3c, s6c). Nat Commun (2020) ncbi
mouse monoclonal (F-5)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6d
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in immunohistochemistry - paraffin section on human samples (fig 6d). Sci Rep (2020) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; loading ...; fig s3e
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on mouse samples (fig s3e). Proc Natl Acad Sci U S A (2019) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 2d
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on human samples (fig 2d). Nature (2019) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:500; loading ...; fig s2e
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on mouse samples at 1:500 (fig s2e). Nature (2019) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:250; loading ...; fig 2h
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on mouse samples at 1:250 (fig 2h). elife (2019) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 0.7 ug/ml; loading ...; fig 4c
Santa Cruz Biotechnology Cdkn1a antibody (Santa, F-5) was used in western blot on mouse samples at 0.7 ug/ml (fig 4c). Science (2019) ncbi
mouse monoclonal (F-5)
  • immunocytochemistry; human; 1:100; loading ...; fig e5c, e5e
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in immunocytochemistry on human samples at 1:100 (fig e5c, e5e). Nature (2019) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig s6c
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples (fig s6c). Sci Adv (2019) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:100; loading ...; fig s8a
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:100 (fig s8a). Cancer Cell (2019) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 7c
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, F-5) was used in western blot on human samples (fig 7c). EMBO J (2019) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; loading ...; fig s7b
Santa Cruz Biotechnology Cdkn1a antibody (Santa, sc-6246) was used in western blot on mouse samples (fig s7b). Nature (2019) ncbi
mouse monoclonal (B-2)
  • western blot; mouse; 1:50; loading ...; fig s1h, s2h
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-271532) was used in western blot on mouse samples at 1:50 (fig s1h, s2h). Hepatology (2019) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 4d
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples (fig 4d). Cell Death Differ (2019) ncbi
mouse monoclonal (F-5)
  • immunohistochemistry knockout validation; human; 1:200; fig 5a
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in immunohistochemistry knockout validation on human samples at 1:200 (fig 5a). Genome Biol (2018) ncbi
mouse monoclonal (187)
  • western blot; human; loading ...; fig 2e
Santa Cruz Biotechnology Cdkn1a antibody (SantaCruz, sc-817) was used in western blot on human samples (fig 2e). Oncotarget (2017) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:200; loading ...; fig 4o
Santa Cruz Biotechnology Cdkn1a antibody (SantaCruz, F-5) was used in western blot on mouse samples at 1:200 (fig 4o). Genes Dev (2017) ncbi
mouse monoclonal (F-5)
  • immunoprecipitation; mouse; loading ...; fig 5b
Santa Cruz Biotechnology Cdkn1a antibody (Sana Cruz Biotechnology, Inc, sc-6246) was used in immunoprecipitation on mouse samples (fig 5b). Cancer Res (2017) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 5c
Santa Cruz Biotechnology Cdkn1a antibody (SantaCruz, sc-6246) was used in western blot on human samples (fig 5c). Oncogene (2017) ncbi
mouse monoclonal (187)
  • western blot; human; loading ...; fig 3f
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-817) was used in western blot on human samples (fig 3f). Life Sci (2017) ncbi
mouse monoclonal (187)
  • western blot; mouse; 1:1000; fig 2g
In order to analyze the contributions of developmental Hedgehog signaling effectors HDAC1 and HDAC2 in SHH Medulloblastoma, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-817) was used in western blot on mouse samples at 1:1000 (fig 2g). Sci Rep (2017) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 3d
In order to identify sex-related factors that regulate the severity of facioscapulohumeral muscular dystrophy, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples (fig 3d). J Clin Invest (2017) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:500; loading ...; fig 7a
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, SC-6246) was used in western blot on mouse samples at 1:500 (fig 7a). Cell Rep (2017) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; loading ...; fig 4b
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on mouse samples (fig 4b). PLoS ONE (2017) ncbi
mouse monoclonal (F-5)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 5d
In order to discover that ATM kinase activity is essential for p21-dependent and p21-independent mechanisms that radioprotect intestinal crypts, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 5d). Sci Rep (2017) ncbi
mouse monoclonal (187)
  • western blot; human; loading ...; fig 5d
In order to report that A549 cell death induced by sodium butyrate and sodium 4-phenylbutyrate occur via distinct pathways, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, SC-817) was used in western blot on human samples (fig 5d). Cancer Med (2017) ncbi
mouse monoclonal (F-5)
  • western blot knockout validation; mouse; loading ...; fig 3d
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot knockout validation on mouse samples (fig 3d). Mol Pharmacol (2017) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:1000; loading ...; fig 5a
In order to determine the effect of 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one on the induction of apoptosis and cell cycle arrest in human bladder carcinoma cells, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:1000 (fig 5a). Mol Med Rep (2017) ncbi
mouse monoclonal (F-5)
  • western blot; rat; 1:250; loading ...; fig 3a
In order to study the impact of homologous recombination and non-homologous end joining to alcohol-induced hippocampal injury, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, Sc-6246) was used in western blot on rat samples at 1:250 (fig 3a). Alcohol (2016) ncbi
mouse monoclonal (187)
  • western blot; human; loading ...; fig 7d
Santa Cruz Biotechnology Cdkn1a antibody (SantaCruz, 187) was used in western blot on human samples (fig 7d). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:200; loading ...; fig 6c
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:200 (fig 6c). Mol Cell Endocrinol (2016) ncbi
mouse monoclonal (F-5)
  • western blot knockout validation; mouse; loading ...; fig 3h
In order to determine the role of p21 in regulating cardiac hypertrophic growth, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot knockout validation on mouse samples (fig 3h). Peptides (2016) ncbi
mouse monoclonal (SX118)
  • western blot; human; loading ...; fig 1f
In order to study how methylation of p53 affects its interactions with other proteins such as PUMA and p300/CBP, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-53870) was used in western blot on human samples (fig 1f). Oncogene (2017) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:500; loading ...; fig 4a
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:500 (fig 4a). Oncotarget (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 3b
In order to discuss the role of Notch1 in prostate cancer, Santa Cruz Biotechnology Cdkn1a antibody (Santa-Cruz, sc-6246) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
mouse monoclonal (F-5)
  • immunocytochemistry; human; loading ...; fig 1f
  • western blot; human; loading ...; fig 1b
In order to characterize the molecular changes involved in human aortic smooth muscle cell proliferation, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, SC-6246) was used in immunocytochemistry on human samples (fig 1f) and in western blot on human samples (fig 1b). Sci Rep (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig 1c
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, F-5) was used in western blot on human samples (fig 1c). Oncotarget (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig s4
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, F-5) was used in western blot on human samples (fig s4). Nucleic Acids Res (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig s1
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples (fig s1). Cell Death Dis (2016) ncbi
mouse monoclonal (F-5)
  • immunohistochemistry - frozen section; mouse; fig 3
In order to describe a role for Nbn in skin homeostasis, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in immunohistochemistry - frozen section on mouse samples (fig 3). Oncotarget (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig 5
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:1000; fig 3a
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on mouse samples at 1:1000 (fig 3a). Oncotarget (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:500; loading ...; fig 8
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:500 (fig 8). PLoS ONE (2016) ncbi
mouse monoclonal (187)
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, 817) was used in western blot on human samples (fig 3a). EMBO Rep (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 5c
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples (fig 5c). Oncogene (2016) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; fig s2
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on mouse samples (fig s2). Sci Rep (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:500; loading ...; fig st3
In order to study the DNA damage response in senescent epithelial cells, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:500 (fig st3). Nat Commun (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:200; fig 3
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:200 (fig 3). Cell Death Dis (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig 5
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples (fig 5). Oncotarget (2016) ncbi
mouse monoclonal (SX118)
  • western blot; human; fig 6
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc53870) was used in western blot on human samples (fig 6). Oncotarget (2016) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:500; loading ...; fig 7a
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, Santa Cruz Biotechnology Cdkn1a antibody (SantaCruz, F-5) was used in western blot on mouse samples at 1:500 (fig 7a). Nat Commun (2016) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:50; fig 1d
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on mouse samples at 1:50 (fig 1d). Aging Cell (2016) ncbi
mouse monoclonal (187)
  • western blot; human; fig 9
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-817) was used in western blot on human samples (fig 9). Genes Cancer (2015) ncbi
mouse monoclonal (B-2)
  • western blot; mouse; 1:400; fig 5
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-271532) was used in western blot on mouse samples at 1:400 (fig 5). Exp Ther Med (2015) ncbi
mouse monoclonal (F-5)
  • western blot; rat; fig 5
Santa Cruz Biotechnology Cdkn1a antibody (Santacruz, sc-6246) was used in western blot on rat samples (fig 5). Physiol Rep (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:500; fig 3
In order to investigate MDM4 exon 6 skipping by antisense oligionucleotides and its affect on inhibiting tumor growth, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on human samples at 1:500 (fig 3). J Clin Invest (2016) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; fig 8
In order to characterize defects in heart development and embryonic lethality due to cardiac-specific activation of IKK2, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on mouse samples (fig 8). PLoS ONE (2015) ncbi
mouse monoclonal (187)
  • immunohistochemistry; human; fig 1
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-817) was used in immunohistochemistry on human samples (fig 1). Mol Cancer (2015) ncbi
mouse monoclonal (187)
  • western blot; human; fig 4
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-817) was used in western blot on human samples (fig 4). Oncogene (2016) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig 6
Santa Cruz Biotechnology Cdkn1a antibody (santa Cruz, sc-6246) was used in western blot on human samples (fig 6). Oncotarget (2015) ncbi
mouse monoclonal (187)
  • western blot; human; 1:500; fig 7
Santa Cruz Biotechnology Cdkn1a antibody (Santa cruz, sc-817) was used in western blot on human samples at 1:500 (fig 7). PLoS ONE (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig 2
Santa Cruz Biotechnology Cdkn1a antibody (santa Cruz, sc-6246) was used in western blot on human samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples . J Proteomics (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples . Int J Oncol (2015) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:500; fig 1
In order to report a role for p53 in regulating the membrane phospholipids composition, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on mouse samples at 1:500 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 4a
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on human samples (fig 4a). Oncotarget (2015) ncbi
mouse monoclonal (F-5)
  • western blot knockout validation; mouse; 1:1000
Santa Cruz Biotechnology Cdkn1a antibody (Santa, sc-6246) was used in western blot knockout validation on mouse samples at 1:1000. PLoS ONE (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig 1
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (F-5)
  • immunoprecipitation; human
  • western blot; human
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in immunoprecipitation on human samples and in western blot on human samples . J Biol Chem (2015) ncbi
mouse monoclonal (F-5)
  • immunocytochemistry; human; fig 1
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in immunocytochemistry on human samples (fig 1). EMBO J (2015) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; fig 6
Santa Cruz Biotechnology Cdkn1a antibody (santa Cruz, sc-6246) was used in western blot on mouse samples (fig 6). PLoS Genet (2015) ncbi
mouse monoclonal (F-5)
  • western blot; mouse
In order to describe the multiple lentiviral expression (MuLE) system that allows multiple genetic alterations to be introduced simultaneously into mammalian cells, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on mouse samples . J Clin Invest (2015) ncbi
mouse monoclonal (F-5)
  • western blot; mouse
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on mouse samples . J Clin Invest (2015) ncbi
mouse monoclonal (F-5)
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used . Aging Cell (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig s2
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples (fig s2). Sci Rep (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig 4
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, F-5) was used in western blot on human samples (fig 4). Mol Cancer (2015) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:300; fig 5
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, F-5) was used in western blot on mouse samples at 1:300 (fig 5). Development (2015) ncbi
mouse monoclonal (SX118)
  • western blot; human; fig 4f
In order to study the role of N-terminal acetylation in Ogden syndrome, Santa Cruz Biotechnology Cdkn1a antibody (Santa, sc-53870) was used in western blot on human samples (fig 4f). Hum Mol Genet (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:500
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples at 1:500. Free Radic Biol Med (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:1000
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on human samples at 1:1000. Biochim Biophys Acta (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human; loading ...; fig 3c
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, F-5) was used in western blot on human samples (fig 3c). Mol Pharm (2015) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:1000
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, SC-6246) was used in western blot on mouse samples at 1:1000. Am J Physiol Endocrinol Metab (2015) ncbi
mouse monoclonal (F-5)
  • western blot; mouse
In order to identify the mechanistic link between Cullin neddylation and Myc ubiquitination/degradation, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on mouse samples . Nat Commun (2014) ncbi
mouse monoclonal (F-5)
  • immunohistochemistry - paraffin section; human; 1:50
  • western blot; human; 1:500
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in immunohistochemistry - paraffin section on human samples at 1:50 and in western blot on human samples at 1:500. Oncotarget (2014) ncbi
mouse monoclonal (F-5)
  • immunocytochemistry; mouse
  • western blot; mouse
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in immunocytochemistry on mouse samples and in western blot on mouse samples . Biochim Biophys Acta (2015) ncbi
mouse monoclonal (F-5)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the anti-tumor effect of CAMK2N1 on prostate cancer progression, Santa Cruz Biotechnology Cdkn1a antibody (Santa cruz, SC-6246) was used in immunohistochemistry - paraffin section on mouse samples . Oncotarget (2014) ncbi
mouse monoclonal (SX118)
  • western blot; mouse; 1:200
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-53870) was used in western blot on mouse samples at 1:200. Cell Physiol Biochem (2014) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig 1
In order to study the effect of ceramide treatment on p53, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples (fig 1). Biochim Biophys Acta (2014) ncbi
mouse monoclonal (F-5)
  • western blot; human; 0.2 ug/ml
Santa Cruz Biotechnology Cdkn1a antibody (Santa, sc-6246) was used in western blot on human samples at 0.2 ug/ml. PLoS ONE (2014) ncbi
mouse monoclonal (F-5)
  • western blot; mouse
  • western blot; human
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, F-5) was used in western blot on mouse samples and in western blot on human samples . Oncogene (2015) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig 6d
Santa Cruz Biotechnology Cdkn1a antibody (Santa, sc6246) was used in western blot on human samples (fig 6d). Oncotarget (2014) ncbi
mouse monoclonal (187)
  • western blot; human; fig 2
Santa Cruz Biotechnology Cdkn1a antibody (santa Cruz, sc-817) was used in western blot on human samples (fig 2). Oncogene (2015) ncbi
mouse monoclonal (F-5)
  • western blot; mouse
In order to examine the role of MYC during tumor development in vivo, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on mouse samples . Cancer Res (2014) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig 6
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on human samples (fig 6). J Pathol (2014) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:1000
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotech, sc-6246) was used in western blot on mouse samples at 1:1000. J Neural Transm (Vienna) (2015) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; fig 1
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on mouse samples (fig 1). J Am Soc Nephrol (2014) ncbi
mouse monoclonal (187)
  • western blot; human
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-817X) was used in western blot on human samples . Cell Death Dis (2014) ncbi
mouse monoclonal (F-5)
  • western blot; human
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples . Exp Cell Res (2014) ncbi
mouse monoclonal (SX118)
  • western blot; human
In order to study the effect of a UBE2N inhibitor on neuroblastoma and its mechanism, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-53870) was used in western blot on human samples . Cell Death Dis (2014) ncbi
mouse monoclonal (F-5)
  • western blot; human; 1:100; fig 3c
In order to study the role of a p53-miRNA-34 positive-feedback loop in tumor suppression in lung cancer, Santa Cruz Biotechnology Cdkn1a antibody (Santa, sc-6246) was used in western blot on human samples at 1:100 (fig 3c). Genes Dev (2014) ncbi
mouse monoclonal (F-5)
  • immunohistochemistry - paraffin section; mouse
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc6246) was used in immunohistochemistry - paraffin section on mouse samples . Exp Toxicol Pathol (2014) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; fig 5
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on mouse samples (fig 5). Mol Pharmacol (2014) ncbi
mouse monoclonal (F-5)
  • western blot; human; fig 6
In order to study the effect of panobinostat treatment on disease using an acute myeloid leukemia mouse model, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, F-5) was used in western blot on human samples (fig 6). Blood (2014) ncbi
mouse monoclonal (F-5)
  • immunohistochemistry - paraffin section; mouse
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc6246) was used in immunohistochemistry - paraffin section on mouse samples . Exp Toxicol Pathol (2013) ncbi
mouse monoclonal (F-5)
  • western blot; human
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on human samples . Cancer Cell Int (2013) ncbi
mouse monoclonal (F-5)
  • western blot; mouse
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc6246) was used in western blot on mouse samples . Oncogene (2014) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; 1:1000
In order to study the role of Smad3 in the effect of TGF-beta in the mammary epithelium, Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on mouse samples at 1:1000. Mol Cancer Res (2012) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; fig 4
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on mouse samples (fig 4). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (F-5)
  • western blot; mouse; fig 1
Santa Cruz Biotechnology Cdkn1a antibody (Santa, sc-6246) was used in western blot on mouse samples (fig 1). Cell Cycle (2011) ncbi
mouse monoclonal (187)
  • western blot; human; fig 3
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-817) was used in western blot on human samples (fig 3). Clin Cancer Res (2010) ncbi
mouse monoclonal (F-5)
  • western blot; mouse
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-6246) was used in western blot on mouse samples . Mol Cell Biol (2010) ncbi
mouse monoclonal (187)
  • immunoprecipitation; human; 1 ug/time
  • western blot; human
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz Biotechnology, sc-817) was used in immunoprecipitation on human samples at 1 ug/time and in western blot on human samples . Oncogene (2007) ncbi
mouse monoclonal (F-5)
  • western blot; human
Santa Cruz Biotechnology Cdkn1a antibody (Santa Cruz, sc-6246) was used in western blot on human samples . FEBS Lett (2006) ncbi
Abcam
domestic rabbit monoclonal (EPR3993)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s8b
Abcam Cdkn1a antibody (Abcam, Ab109199) was used in immunohistochemistry - paraffin section on mouse samples (fig s8b). Oncogene (2022) ncbi
rat monoclonal (HUGO291)
  • immunohistochemistry; mouse; 1:300; loading ...; fig s2-2b
Abcam Cdkn1a antibody (Abcam, ab107099) was used in immunohistochemistry on mouse samples at 1:300 (fig s2-2b). elife (2021) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; rat; loading ...; fig s4b
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on rat samples (fig s4b). J Cell Biol (2021) ncbi
domestic rabbit monoclonal (EPR18021)
  • western blot; mouse; 1:1000; loading ...; fig 6b
Abcam Cdkn1a antibody (Abcam, 188224) was used in western blot on mouse samples at 1:1000 (fig 6b). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (EPR18021)
  • immunohistochemistry; mouse; 1:2000; loading ...; fig 7c
Abcam Cdkn1a antibody (Abcam, Ab188224) was used in immunohistochemistry on mouse samples at 1:2000 (fig 7c). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (EPR18021)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 3d
Abcam Cdkn1a antibody (Abcam, ab188224) was used in immunohistochemistry on mouse samples at 1:1000 (fig 3d). Metabolites (2021) ncbi
domestic rabbit monoclonal (EPR18021)
  • immunohistochemistry; pigs ; loading ...; fig 4g
Abcam Cdkn1a antibody (Abcam, ab188224) was used in immunohistochemistry on pigs samples (fig 4g). Sci Rep (2021) ncbi
domestic rabbit monoclonal (EPR18021)
  • western blot; human; loading ...; fig 3j
Abcam Cdkn1a antibody (Abcam, ab188224) was used in western blot on human samples (fig 3j). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; mouse; loading ...; fig 4b
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on mouse samples (fig 4b). Aging Cell (2021) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; mouse; loading ...; fig 1j
Abcam Cdkn1a antibody (Abcam, EPR3993) was used in western blot on mouse samples (fig 1j). J Clin Invest (2021) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; rat; 1:1000; loading ...; fig 2g
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 1c
  • western blot; mouse; 1:1000; loading ...; fig 1e
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on rat samples at 1:1000 (fig 2g), in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 1c) and in western blot on mouse samples at 1:1000 (fig 1e). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; mouse; 1:1000; loading ...; fig 3f
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on mouse samples at 1:1000 (fig 3f). PLoS ONE (2021) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; human; 1:1000; loading ...; fig 3a
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on human samples at 1:1000 (fig 3a). World J Surg Oncol (2021) ncbi
rat monoclonal (HUGO291)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4e
Abcam Cdkn1a antibody (Abcam, ab107099) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4e). EMBO J (2021) ncbi
domestic rabbit monoclonal (EPR18021)
  • western blot; human; 1:1000; loading ...; fig 5a
Abcam Cdkn1a antibody (Abcam, ab188224) was used in western blot on human samples at 1:1000 (fig 5a). Cancer Cell Int (2021) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; human; 1:1000
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on human samples at 1:1000. Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (EPR18021)
  • western blot knockout validation; mouse; 1:500; loading ...; fig 1f
  • immunoprecipitation; mouse; loading ...; fig 6a
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3b
Abcam Cdkn1a antibody (Abcam, ab188224) was used in western blot knockout validation on mouse samples at 1:500 (fig 1f), in immunoprecipitation on mouse samples (fig 6a) and in immunohistochemistry on mouse samples at 1:500 (fig 3b). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (HUGO291)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7a
  • western blot; mouse; loading ...; fig 3c
Abcam Cdkn1a antibody (Abcam, ab107099) was used in immunohistochemistry - paraffin section on mouse samples (fig 7a) and in western blot on mouse samples (fig 3c). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; rat; loading ...; fig 9e
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on rat samples (fig 9e). Theranostics (2021) ncbi
rat monoclonal (HUGO291)
  • immunohistochemistry - paraffin section; mouse; 1:150; loading ...
Abcam Cdkn1a antibody (Abcam, ab107099) was used in immunohistochemistry - paraffin section on mouse samples at 1:150. Genes Dev (2021) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; mouse; 1:1000; loading ...; fig 2c
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on mouse samples at 1:1000 (fig 2c). Adipocyte (2020) ncbi
domestic rabbit monoclonal (EPR3993)
  • flow cytometry; human; 1:200; loading ...; fig s5c
  • western blot; human; 1:1000; fig s2b
Abcam Cdkn1a antibody (Abcam, ab109199) was used in flow cytometry on human samples at 1:200 (fig s5c) and in western blot on human samples at 1:1000 (fig s2b). Science (2020) ncbi
rat monoclonal (HUGO291)
  • western blot; mouse; 1:1000; loading ...; fig 4b
Abcam Cdkn1a antibody (Abcam, ab107099) was used in western blot on mouse samples at 1:1000 (fig 4b). J Clin Invest (2020) ncbi
domestic rabbit monoclonal (EPR18021)
  • western blot; human; 1:2000; loading ...; fig 5e
Abcam Cdkn1a antibody (Abcam, ab188224) was used in western blot on human samples at 1:2000 (fig 5e). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (EPR18021)
  • western blot; mouse; 1:1000; loading ...; fig 3f, 7b
Abcam Cdkn1a antibody (Abcam, ab188224) was used in western blot on mouse samples at 1:1000 (fig 3f, 7b). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (EPR18021)
  • immunoprecipitation; mouse; loading ...; fig 2a
  • western blot; mouse; loading ...; fig 1a
Abcam Cdkn1a antibody (Abcam, ab188224) was used in immunoprecipitation on mouse samples (fig 2a) and in western blot on mouse samples (fig 1a). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (EPR18021)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 7d
Abcam Cdkn1a antibody (AbCam, ab188224) was used in immunohistochemistry - frozen section on mouse samples (fig 7d). Cell Stem Cell (2019) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; mouse; 1:1000; loading ...; fig 3c
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on mouse samples at 1:1000 (fig 3c). Biosci Rep (2019) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; rat; 1:1000; loading ...; fig 5b
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on rat samples at 1:1000 (fig 5b). Cell Death Dis (2019) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; rat; fig 2b
  • western blot; human; 1:1500; loading ...; fig 2b
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on rat samples (fig 2b) and in western blot on human samples at 1:1500 (fig 2b). J Exp Clin Cancer Res (2019) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; rat; loading ...; fig 1b
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on rat samples (fig 1b). Braz J Med Biol Res (2019) ncbi
domestic rabbit monoclonal (EPR3993)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 2a
  • immunocytochemistry; mouse; 1:200; loading ...; fig 3c
  • western blot; mouse; loading ...; fig 3a
Abcam Cdkn1a antibody (Abcam, ab109199) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 2a), in immunocytochemistry on mouse samples at 1:200 (fig 3c) and in western blot on mouse samples (fig 3a). Biomed Pharmacother (2019) ncbi
rat monoclonal (HUGO291)
  • western blot; human; loading ...; fig s1c, s2b
  • western blot; mouse; loading ...; fig 5h, 5i
Abcam Cdkn1a antibody (Abcam, ab107099) was used in western blot on human samples (fig s1c, s2b) and in western blot on mouse samples (fig 5h, 5i). Nucleic Acids Res (2018) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; rat; 1:1000; loading ...; fig 6c
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on rat samples at 1:1000 (fig 6c). Biosci Rep (2018) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; mouse; fig 6c
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on mouse samples (fig 6c). Cell Signal (2018) ncbi
domestic rabbit monoclonal (EPR3993)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 8f
Abcam Cdkn1a antibody (Abcam, ab109199) was used in immunohistochemistry on mouse samples at 1:500 (fig 8f). Cell Death Dis (2018) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; human; fig 3g
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on human samples (fig 3g). Science (2017) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; mouse; 1:1000; loading ...; fig 4f
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on mouse samples at 1:1000 (fig 4f). Redox Biol (2017) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; mouse; 1:1000; fig s1
Abcam Cdkn1a antibody (abcam, ab109199) was used in western blot on mouse samples at 1:1000 (fig s1). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; mouse; 1:1000; fig 3b
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on mouse samples at 1:1000 (fig 3b). FEBS Open Bio (2015) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; human; 1:2000; loading ...; fig 1b
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on human samples at 1:2000 (fig 1b). Oncotarget (2015) ncbi
domestic rabbit monoclonal (EPR3993)
  • western blot; mouse
Abcam Cdkn1a antibody (Abcam, ab109199) was used in western blot on mouse samples . PLoS ONE (2015) ncbi
Novus Biologicals
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1h
Novus Biologicals Cdkn1a antibody (Novus, NB100-1941) was used in immunohistochemistry on mouse samples at 1:200 (fig 1h). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig 2c
  • western blot; mouse; loading ...; fig 2h
Novus Biologicals Cdkn1a antibody (NOVUS, NB100-1941) was used in immunohistochemistry on mouse samples (fig 2c) and in western blot on mouse samples (fig 2h). Signal Transduct Target Ther (2021) ncbi
mouse monoclonal (WA-1)
  • western blot; mouse; loading ...; fig 4a
Novus Biologicals Cdkn1a antibody (Novus, NBP2-29463) was used in western blot on mouse samples (fig 4a). Proc Natl Acad Sci U S A (2021) ncbi
mouse monoclonal (WA-1)
  • western blot; mouse; 1:50; loading ...; fig 7a
In order to study the interaction between Hap1 and Dcaf7, Novus Biologicals Cdkn1a antibody (Novus, NBP2-29463) was used in western blot on mouse samples at 1:50 (fig 7a). Proc Natl Acad Sci U S A (2017) ncbi
Invitrogen
mouse monoclonal (HJ21)
  • immunohistochemistry; mouse; loading ...; fig 5b
Invitrogen Cdkn1a antibody (Invitrogen, AHZ0422) was used in immunohistochemistry on mouse samples (fig 5b). Exp Mol Med (2021) ncbi
mouse monoclonal (HJ21)
  • western blot; mouse; fig 5
In order to determine the role of uncoupling of p53/p21-Waf1 signaling and G1 checkpoint disruption in mouse ESCs, Invitrogen Cdkn1a antibody (Invitrogen, AHZ0422) was used in western blot on mouse samples (fig 5). Cell Cycle (2016) ncbi
mouse monoclonal (HJ21)
  • immunocytochemistry; human; 1:100; fig 6
  • western blot; human; 1:5000; fig 4
In order to suggest that suppression mTORC1 activity prevents replicative senescence without transformation of rodent cells, Invitrogen Cdkn1a antibody (Invitrogen, AHZ0422) was used in immunocytochemistry on human samples at 1:100 (fig 6) and in western blot on human samples at 1:5000 (fig 4). Cell Cycle (2013) ncbi
mouse monoclonal (HJ21)
  • western blot; mouse; 1:50; fig 1
In order to determine the role of p21(Waf1) in the transformation process using mouse embryo fibroblasts, Invitrogen Cdkn1a antibody (Invitrogen, AHZ0422) was used in western blot on mouse samples at 1:50 (fig 1). Biochimie (2011) ncbi
BD Biosciences
mouse monoclonal (SX118)
  • western blot; mouse; 1:1000; loading ...; fig s5f
BD Biosciences Cdkn1a antibody (BD Biosciences, 556430) was used in western blot on mouse samples at 1:1000 (fig s5f). Cell Death Dis (2022) ncbi
mouse monoclonal (SXM30)
  • immunohistochemistry; mouse; loading ...
BD Biosciences Cdkn1a antibody (BD Biosciences, 556431) was used in immunohistochemistry on mouse samples . Cell Rep (2021) ncbi
mouse monoclonal (SXM30)
  • western blot; mouse; loading ...; fig 1e
BD Biosciences Cdkn1a antibody (BD Biosciences, 556431) was used in western blot on mouse samples (fig 1e). Cell Death Discov (2021) ncbi
mouse monoclonal (SXM30)
  • western blot; human; 1:2000; loading ...; fig 2e
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556,431) was used in western blot on human samples at 1:2000 (fig 2e). Arch Toxicol (2021) ncbi
mouse monoclonal (SXM30)
  • immunohistochemistry; mouse; 1:1000; fig s1h
BD Biosciences Cdkn1a antibody (BD, 556431) was used in immunohistochemistry on mouse samples at 1:1000 (fig s1h). Nature (2019) ncbi
mouse monoclonal (SXM30)
  • immunohistochemistry - frozen section; mouse; 1:50; loading ...; fig 1d
BD Biosciences Cdkn1a antibody (BD Biosciences, 556431) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig 1d). elife (2019) ncbi
mouse monoclonal (SXM30)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 1e
  • western blot; human; 1:1000; loading ...; fig 1g
BD Biosciences Cdkn1a antibody (BD Pharmingen, PMG556431) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1e) and in western blot on human samples at 1:1000 (fig 1g). EMBO J (2019) ncbi
mouse monoclonal (SX118)
  • western blot; mouse; 1:1000; loading ...; fig 6f
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556430) was used in western blot on mouse samples at 1:1000 (fig 6f). Stem Cell Reports (2019) ncbi
mouse monoclonal (SXM30)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 6c, s2d
BD Biosciences Cdkn1a antibody (BD Pharmingene, 556431) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 6c, s2d). Sci Adv (2019) ncbi
mouse monoclonal (SXM30)
  • western blot; human; loading ...; fig s1a
BD Biosciences Cdkn1a antibody (BD Biosciences, 556431) was used in western blot on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (SX118)
  • western blot; mouse; loading ...; fig 3e
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556430) was used in western blot on mouse samples (fig 3e). Cell Death Dis (2018) ncbi
mouse monoclonal (SX118)
  • western blot; human; loading ...; fig 6
BD Biosciences Cdkn1a antibody (BD, 556430) was used in western blot on human samples (fig 6). Oncotarget (2017) ncbi
mouse monoclonal (SX118)
  • western blot; human; loading ...; fig 6a
BD Biosciences Cdkn1a antibody (BD Biosciences, 556430) was used in western blot on human samples (fig 6a). Cell Death Dis (2017) ncbi
mouse monoclonal (SXM30)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 3i
In order to elucidate novel functions of the senescence-associated secretory in promoting a proregenerative response through the induction of cell plasticity and stemness, BD Biosciences Cdkn1a antibody (BD Pharmingen, SXM30) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 3i). Genes Dev (2017) ncbi
mouse monoclonal (SX118)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 7h
  • western blot; human; 1:2000; loading ...; fig 3g
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556430) was used in immunohistochemistry on mouse samples at 1:1000 (fig 7h) and in western blot on human samples at 1:2000 (fig 3g). Nat Commun (2017) ncbi
mouse monoclonal (SXM30)
  • western blot; mouse; 1:2000; loading ...; fig 2a
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556431) was used in western blot on mouse samples at 1:2000 (fig 2a). Int J Cancer (2017) ncbi
mouse monoclonal (SXM30)
  • western blot; human; 1:500; loading ...; fig 2c
In order to identify and characterize an inhibitor of the COP9 signalosome, BD Biosciences Cdkn1a antibody (BD Biosciences, 556431) was used in western blot on human samples at 1:500 (fig 2c). Nat Commun (2016) ncbi
mouse monoclonal (SXM30)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6c
In order to elucidate the role of NOTCH1 in oncogene-induced senescence, BD Biosciences Cdkn1a antibody (BD, 556431) was used in immunohistochemistry - paraffin section on mouse samples (fig 6c). Nat Cell Biol (2016) ncbi
mouse monoclonal (SX118)
  • western blot; human; 1:500; loading ...; fig 6,7d
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556430) was used in western blot on human samples at 1:500 (fig 6,7d). Oncotarget (2016) ncbi
mouse monoclonal (SX118)
  • western blot; human; fig 1
BD Biosciences Cdkn1a antibody (bD Bioscience, SX118) was used in western blot on human samples (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (SXM30)
  • immunohistochemistry; mouse; 1:10; loading ...; fig s1
In order to propose that the NKX3.1-G9a-UTY transcriptional regulatory network is essential for prostate differentiation, BD Biosciences Cdkn1a antibody (BD Bioscience, 556431) was used in immunohistochemistry on mouse samples at 1:10 (fig s1). Science (2016) ncbi
mouse monoclonal (SXM30)
  • western blot; mouse; loading ...; fig 1e
In order to investigate the role of growth hormone in colon cancer, BD Biosciences Cdkn1a antibody (BD Pharmigen, 556431) was used in western blot on mouse samples (fig 1e). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (SX118)
  • western blot; mouse; fig 3
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556430) was used in western blot on mouse samples (fig 3). Cell Rep (2016) ncbi
mouse monoclonal (SX118)
  • western blot; mouse; fig 3
BD Biosciences Cdkn1a antibody (BD Bioscience, 556430) was used in western blot on mouse samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (SXM30)
  • western blot; human; fig 1
  • western blot; mouse; fig 1
In order to elucidate inhibition of BCL-W and BCL-XL by directed elimination of senescent cells, BD Biosciences Cdkn1a antibody (BD Bioscience, 556431) was used in western blot on human samples (fig 1) and in western blot on mouse samples (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (SX118)
  • western blot; human; fig 3a
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556430) was used in western blot on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (SX118)
  • western blot; mouse; fig s1
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556430) was used in western blot on mouse samples (fig s1). Cell Death Differ (2016) ncbi
mouse monoclonal (SXM30)
  • western blot; human; fig 6
In order to characterize multiple molecularly defined cancer indications by studying ROS1, ALK inhibitor, Entrectinib, a Pan-TRK activity, BD Biosciences Cdkn1a antibody (BD Biosciences, 556431) was used in western blot on human samples (fig 6). Mol Cancer Ther (2016) ncbi
mouse monoclonal (SX118)
  • western blot; human; loading ...; fig 4e
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556430) was used in western blot on human samples (fig 4e). Nat Commun (2016) ncbi
mouse monoclonal (SX118)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences Cdkn1a antibody (BD, SX118) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (SXM30)
  • western blot; mouse; 1:2000; fig s4
BD Biosciences Cdkn1a antibody (BD Bioscience, 556431) was used in western blot on mouse samples at 1:2000 (fig s4). DNA Repair (Amst) (2016) ncbi
mouse monoclonal (SX118)
  • western blot; human; fig 2
BD Biosciences Cdkn1a antibody (BD Biosciences, 556430) was used in western blot on human samples (fig 2). Redox Biol (2016) ncbi
mouse monoclonal (SX118)
  • western blot; human; 1:1000; fig 4b
In order to study the relationship between arginine methylation and ubiquitylation in carcinogenesis and KLF4-mediated stability, BD Biosciences Cdkn1a antibody (BD Bioscience, 556430) was used in western blot on human samples at 1:1000 (fig 4b). Nat Commun (2015) ncbi
mouse monoclonal (SX118)
  • western blot; human; fig 11
BD Biosciences Cdkn1a antibody (Pharmingen, 55643) was used in western blot on human samples (fig 11). J Biol Chem (2015) ncbi
mouse monoclonal (SXM30)
  • western blot; human; fig 11
BD Biosciences Cdkn1a antibody (Pharmingen, 55643) was used in western blot on human samples (fig 11). J Biol Chem (2015) ncbi
mouse monoclonal (SXM30)
  • western blot; human; fig 3d
BD Biosciences Cdkn1a antibody (BD Biosciences, 556431) was used in western blot on human samples (fig 3d). Oncotarget (2015) ncbi
mouse monoclonal (SXM30)
  • western blot; human; 1:500
In order to study the effects of donor age and passage number on the efficiency of iPSC induction, BD Biosciences Cdkn1a antibody (Pharmingen, 556431) was used in western blot on human samples at 1:500. Stem Cell Res (2015) ncbi
mouse monoclonal (SX118)
  • western blot; mouse; fig s3
BD Biosciences Cdkn1a antibody (BD, 556430) was used in western blot on mouse samples (fig s3). J Cell Biol (2015) ncbi
mouse monoclonal (SX118)
  • western blot; mouse; 1:2000; fig 3
BD Biosciences Cdkn1a antibody (BD, 556430) was used in western blot on mouse samples at 1:2000 (fig 3). Nucleic Acids Res (2015) ncbi
mouse monoclonal (SXM30)
  • western blot; human; 1:1000; fig 1
BD Biosciences Cdkn1a antibody (BD PharMingen, 556431) was used in western blot on human samples at 1:1000 (fig 1). Cell Cycle (2015) ncbi
mouse monoclonal (SXM30)
  • western blot; human
In order to study the role of p53 stabilization in the effects of chemotherapy drugs, BD Biosciences Cdkn1a antibody (BD Pharmingen, 556431) was used in western blot on human samples . Oncogene (2016) ncbi
mouse monoclonal (SXM30)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 1
In order to show that Lhx4 is needed for efficient pituitary progenitor cell proliferation and restriction of p21 expression, BD Biosciences Cdkn1a antibody (BD Pharmingen, 556431) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1). Mol Endocrinol (2015) ncbi
mouse monoclonal (SXM30)
  • western blot; mouse
BD Biosciences Cdkn1a antibody (BD Bioscience, SXM30) was used in western blot on mouse samples . Neoplasia (2015) ncbi
mouse monoclonal (SXM30)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556431) was used in immunohistochemistry - paraffin section on mouse samples at 1:50. elife (2015) ncbi
mouse monoclonal (SXM30)
  • western blot; human; 1:2000; fig 1
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556431) was used in western blot on human samples at 1:2000 (fig 1). Arch Toxicol (2016) ncbi
mouse monoclonal (SXM30)
  • western blot; human
BD Biosciences Cdkn1a antibody (BD, 556431) was used in western blot on human samples . Oncogene (2015) ncbi
mouse monoclonal (SX118)
  • western blot; human
BD Biosciences Cdkn1a antibody (BD Biosciences, 556430) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (SX118)
  • western blot; human; fig 2
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556430) was used in western blot on human samples (fig 2). Methods Mol Biol (2014) ncbi
mouse monoclonal (SXM30)
  • western blot; mouse; fig 6a
In order to assess intrinsic age-dependent changes in tubular epithelial proliferation in young and old mice, BD Biosciences Cdkn1a antibody (BD, 556431) was used in western blot on mouse samples (fig 6a). PLoS ONE (2014) ncbi
mouse monoclonal (SX118)
  • western blot; rat; 1:1000
BD Biosciences Cdkn1a antibody (BD Pharmingen, 556430) was used in western blot on rat samples at 1:1000. Biochim Biophys Acta (2014) ncbi
mouse monoclonal (SX118)
  • western blot; mouse
In order to investigate the effect of p53 acetylation on DNA damage-induced neuronal apoptosis, BD Biosciences Cdkn1a antibody (BD Pharmingen, 556430) was used in western blot on mouse samples . J Neurosci (2013) ncbi
mouse monoclonal (SXM30)
  • western blot; mouse
In order to examine the possible role of caspase-2 as a tumor suppressor in the mouse mammary carcinogenesis model, BD Biosciences Cdkn1a antibody (BD Biosciences, SXM30) was used in western blot on mouse samples . Cell Death Differ (2013) ncbi
mouse monoclonal (SXM30)
  • western blot; human
BD Biosciences Cdkn1a antibody (BD Biosciences, SXM30) was used in western blot on human samples . Cell Death Differ (2008) ncbi
Articles Reviewed
  1. Aboouf M, Armbruster J, Thiersch M, Guscetti F, Kristiansen G, Schraml P, et al. Pro-Apoptotic and Anti-Invasive Properties Underscore the Tumor-Suppressing Impact of Myoglobin on a Subset of Human Breast Cancer Cells. Int J Mol Sci. 2022;23: pubmed publisher
  2. Narayan S, Raza A, Mahmud I, Koo N, Garrett T, LAW M, et al. Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A. iScience. 2022;25:104518 pubmed publisher
  3. Geng F, Yang W, Song D, Hou H, Han B, Chen Y, et al. MDIG, a 2‑oxoglutarate‑dependent oxygenase, acts as an oncogene and predicts the prognosis of multiple types of cancer. Int J Oncol. 2022;61: pubmed publisher
  4. Jia F, Li H, Jiao Q, Li C, Fu L, Cui C, et al. Deubiquitylase OTUD3 prevents Parkinson's disease through stabilizing iron regulatory protein 2. Cell Death Dis. 2022;13:418 pubmed publisher
  5. Chen Z, Wu W, Zheng C, Lan Y, Xie H, Xie Z. KLF6 facilitates differentiation of odontoblasts through modulating the expression of P21 in vitro. Int J Oral Sci. 2022;14:20 pubmed publisher
  6. Kidger A, Saville M, Rushworth L, Davidson J, Stellzig J, Ono M, et al. Suppression of mutant Kirsten-RAS (KRASG12D)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6. Oncogene. 2022;41:2811-2823 pubmed publisher
  7. Feng X, Guo J, An G, Wu Y, Liu Z, Meng B, et al. Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma. Adv Sci (Weinh). 2022;9:e2104491 pubmed publisher
  8. Xia R, Liu T, Li W, Xu X. RNA-binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA. Clin Transl Med. 2021;11:e383 pubmed publisher
  9. Novais E, Tran V, Johnston S, Darris K, Roupas A, Sessions G, et al. Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat Commun. 2021;12:5213 pubmed publisher
  10. Viais R, Fariña Mosquera M, Villamor Payà M, Watanabe S, Palenzuela L, Lacasa C, et al. Augmin deficiency in neural stem cells causes p53-dependent apoptosis and aborts brain development. elife. 2021;10: pubmed publisher
  11. Song L, Tian X, Schekman R. Extracellular vesicles from neurons promote neural induction of stem cells through cyclin D1. J Cell Biol. 2021;220: pubmed publisher
  12. Prekovic S, Schuurman K, Mayayo Peralta I, Manjón A, Buijs M, Yavuz S, et al. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Nat Commun. 2021;12:4360 pubmed publisher
  13. Urrutia G, de Assunção T, Mathison A, Salmonson A, Kerketta R, Zeighami A, et al. Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks. Front Cell Dev Biol. 2021;9:681153 pubmed publisher
  14. Marquez Exposito L, Tejedor Santamaria L, Santos Sánchez L, Valentijn F, Cantero Navarro E, Rayego Mateos S, et al. Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes. Front Pharmacol. 2021;12:662020 pubmed publisher
  15. Chronowski C, Akhanov V, CHAN D, Catic A, Finegold M, Sahin E. Fructose Causes Liver Damage, Polyploidy, and Dysplasia in the Setting of Short Telomeres and p53 Loss. Metabolites. 2021;11: pubmed publisher
  16. Bailey K, Cartwright S, Patel N, Remmers N, Lazenby A, Hollingsworth M, et al. Porcine pancreatic ductal epithelial cells transformed with KRASG12D and SV40T are tumorigenic. Sci Rep. 2021;11:13436 pubmed publisher
  17. Zhang Y, Hu M, Yang F, Zhang Y, Ma S, Zhang D, et al. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance. J Mol Med (Berl). 2021;99:1427-1446 pubmed publisher
  18. Yuan Y, Cao W, Zhou H, Qian H, Wang H. H2A.Z acetylation by lincZNF337-AS1 via KAT5 implicated in the transcriptional misregulation in cancer signaling pathway in hepatocellular carcinoma. Cell Death Dis. 2021;12:609 pubmed publisher
  19. Lee H, Donati A, Feliers D, Sun Y, Ding Y, Madesh M, et al. Chloride channel accessory 1 integrates chloride channel activity and mTORC1 in aging-related kidney injury. Aging Cell. 2021;20:e13407 pubmed publisher
  20. Gan L, Liu D, Liu J, Chen E, Chen C, Liu L, et al. CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice. Signal Transduct Target Ther. 2021;6:223 pubmed publisher
  21. Sanchez Rivera F, Ryan J, Soto Feliciano Y, Clare Beytagh M, Xuan L, Feldser D, et al. Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  22. Kim C, Jin J, Ye Z, Jadhav R, Gustafson C, Hu B, et al. Histone deficiency and accelerated replication stress in T cell aging. J Clin Invest. 2021;131: pubmed publisher
  23. Huang P, Bai L, Liu L, Fu J, Wu K, Liu H, et al. Redd1 knockdown prevents doxorubicin-induced cardiac senescence. Aging (Albany NY). 2021;13:13788-13806 pubmed publisher
  24. Morimune T, Tano A, Tanaka Y, Yukiue H, Yamamoto T, Tooyama I, et al. Gm14230 controls Tbc1d24 cytoophidia and neuronal cellular juvenescence. PLoS ONE. 2021;16:e0248517 pubmed publisher
  25. Li W, Zheng J, Zhao G, Lyu C, Lu W. Overexpression of DSCR1 prevents proliferation and predicts favorable prognosis in colorectal cancer patients. World J Surg Oncol. 2021;19:100 pubmed publisher
  26. Lee S, Park K, Lee G, Kim S, Song W, Kwon S, et al. Hypoxia-inducible factor-2α mediates senescence-associated intrinsic mechanisms of age-related bone loss. Exp Mol Med. 2021;53:591-604 pubmed publisher
  27. Plácido L, Romero Y, Maldonado M, Toscano Marquez F, Ramirez R, Calyeca J, et al. Loss of MT1-MMP in Alveolar Epithelial Cells Exacerbates Pulmonary Fibrosis. Int J Mol Sci. 2021;22: pubmed publisher
  28. Lagnado A, Leslie J, Ruchaud Sparagano M, Victorelli S, Hirsova P, Ogrodnik M, et al. Neutrophils induce paracrine telomere dysfunction and senescence in ROS-dependent manner. EMBO J. 2021;40:e106048 pubmed publisher
  29. Goncalves S, Yin K, Ito Y, Chan A, Olan I, Gough S, et al. COX2 regulates senescence secretome composition and senescence surveillance through PGE2. Cell Rep. 2021;34:108860 pubmed publisher
  30. Pairawan S, Zhao M, Yuca E, Annis A, Evans K, Sutton D, et al. First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models. Breast Cancer Res. 2021;23:29 pubmed publisher
  31. Kumar B, Ahmad R, Giannico G, Zent R, Talmon G, Harris R, et al. Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation. J Exp Clin Cancer Res. 2021;40:77 pubmed publisher
  32. Chen J, Xu D, Cao J, Zuo L, Han Z, Tian Y, et al. TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination. Cancer Cell Int. 2021;21:129 pubmed publisher
  33. Lee J, Park I, Kwak M, Rhee W, Kim S, Shin J. HMGB1 orchestrates STING-mediated senescence via TRIM30α modulation in cancer cells. Cell Death Discov. 2021;7:28 pubmed publisher
  34. Buj R, Leon K, Anguelov M, Aird K. Suppression of p16 alleviates the senescence-associated secretory phenotype. Aging (Albany NY). 2021;13:3290-3312 pubmed publisher
  35. Rothmiller S, Jäger N, Meier N, Meyer T, Neu A, Steinritz D, et al. Chronic senescent human mesenchymal stem cells as possible contributor to the wound healing disorder after exposure to the alkylating agent sulfur mustard. Arch Toxicol. 2021;95:727-747 pubmed publisher
  36. Buitrago Molina L, Marhenke S, Becker D, Geffers R, Itzel T, Teufel A, et al. p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury Model. Cell Mol Gastroenterol Hepatol. 2021;11:1387-1404 pubmed publisher
  37. Chibaya L, Karim B, Zhang H, Jones S. Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  38. Guo Q, Chen X, Chen J, Zheng G, Xie C, Wu H, et al. STING promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the NF-κB signaling pathway. Cell Death Dis. 2021;12:13 pubmed publisher
  39. Jiang Y, Xiang C, Zhong F, Zhang Y, Wang L, Zhao Y, et al. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Theranostics. 2021;11:361-378 pubmed publisher
  40. Reedich E, Kalski M, Armijo N, Cox G, DiDonato C. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn2B/- mouse model of spinal muscular atrophy. Exp Neurol. 2021;337:113587 pubmed publisher
  41. Humpton T, Nomura K, Weber J, Magnussen H, Hock A, Nixon C, et al. Differential requirements for MDM2 E3 activity during embryogenesis and in adult mice. Genes Dev. 2021;35:117-132 pubmed publisher
  42. Dewhurst M, Ow J, Zafer G, Van Hul N, Wollmann H, Bisteau X, et al. Loss of hepatocyte cell division leads to liver inflammation and fibrosis. PLoS Genet. 2020;16:e1009084 pubmed publisher
  43. Wueest S, Lucchini F, Haim Y, Rudich A, Konrad D. Depletion of ASK1 blunts stress-induced senescence in adipocytes. Adipocyte. 2020;9:535-541 pubmed publisher
  44. Zatulovskiy E, Zhang S, Berenson D, Topacio B, Skotheim J. Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division. Science. 2020;369:466-471 pubmed publisher
  45. Hu D, Dong R, Zhang Y, Yang Y, Chen Z, Tang Y, et al. Age‑related changes in mineralocorticoid receptors in rat hearts. Mol Med Rep. 2020;22:1859-1867 pubmed publisher
  46. Alajati A, D Ambrosio M, Troiani M, Mosole S, Pellegrini L, Chen J, et al. CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. J Clin Invest. 2020;130:2435-2450 pubmed publisher
  47. Lochab S, Singh Y, Sengupta S, Nandicoori V. Mycobacterium tuberculosis exploits host ATM kinase for survival advantage through SecA2 secretome. elife. 2020;9: pubmed publisher
  48. Zhang J, Huang J, Zhang Y, Zhang X, Zhao L, Li C, et al. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3. EBioMedicine. 2020;53:102701 pubmed publisher
  49. Lin Y, Huang X, Chang K, Liao K, Tsai N. Encapsulated n-Butylidenephthalide Efficiently Crosses the Blood-Brain Barrier and Suppresses Growth of Glioblastoma. Int J Nanomedicine. 2020;15:749-760 pubmed publisher
  50. Huang S, Zhang C, Sun C, Hou Y, Zhang Y, Tam N, et al. Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma. Aging (Albany NY). 2020;12:3025-3041 pubmed publisher
  51. Zhang C, Xie Y, Chen H, Lv L, Yao J, Zhang M, et al. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice. Aging (Albany NY). 2020;12:1272-1284 pubmed publisher
  52. Cassidy L, Young A, Young C, Soilleux E, Fielder E, Weigand B, et al. Temporal inhibition of autophagy reveals segmental reversal of ageing with increased cancer risk. Nat Commun. 2020;11:307 pubmed publisher
  53. Aldaz P, Otaegi Ugartemendia M, Sáenz Antoñanzas A, Garcia Puga M, Moreno Valladares M, Flores J, et al. SOX9 promotes tumor progression through the axis BMI1-p21CIP. Sci Rep. 2020;10:357 pubmed publisher
  54. Li B, Li M, Li X, Li H, Lai Y, Huang S, et al. Sirt1-inducible deacetylation of p21 promotes cardiomyocyte proliferation. Aging (Albany NY). 2019;11:12546-12567 pubmed publisher
  55. Ko H, Hwang I, Jin E, Yun T, Ryu D, Kang J, et al. Roles of ErbB3-binding protein 1 (EBP1) in embryonic development and gene-silencing control. Proc Natl Acad Sci U S A. 2019;116:24852-24860 pubmed publisher
  56. Wang C, Vegna S, Jin H, Benedict B, Lieftink C, Ramirez C, et al. Inducing and exploiting vulnerabilities for the treatment of liver cancer. Nature. 2019;: pubmed publisher
  57. Riessland M, Kolisnyk B, Kim T, Cheng J, Ni J, Pearson J, et al. Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons. Cell Stem Cell. 2019;25:514-530.e8 pubmed publisher
  58. Morris J, Yashinskie J, Koche R, Chandwani R, Tian S, Chen C, et al. α-Ketoglutarate links p53 to cell fate during tumour suppression. Nature. 2019;573:595-599 pubmed publisher
  59. McMahon M, Contreras A, Holm M, Uechi T, Forester C, Pang X, et al. A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS. elife. 2019;8: pubmed publisher
  60. Diaz Osterman C, Ozmadenci D, Kleinschmidt E, Taylor K, Barrie A, Jiang S, et al. FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy. elife. 2019;8: pubmed publisher
  61. Gal H, Lysenko M, Stroganov S, Vadai E, Youssef S, Tzadikevitch Geffen K, et al. Molecular pathways of senescence regulate placental structure and function. EMBO J. 2019;38:e100849 pubmed publisher
  62. Gao X, Chen H, Liu J, Shen S, Wang Q, Clement T, et al. The REGγ-Proteasome Regulates Spermatogenesis Partially by P53-PLZF Signaling. Stem Cell Reports. 2019;13:559-571 pubmed publisher
  63. Xie X, Wang Y, Xia Y, Mao Y. Overexpressed vascular endothelial growth factor in adipose derived stem cells attenuates fibroblasts and skin injuries by ultraviolet radiation. Biosci Rep. 2019;39: pubmed publisher
  64. Hari P, Millar F, Tarrats N, Birch J, Quintanilla A, Rink C, et al. The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype. Sci Adv. 2019;5:eaaw0254 pubmed publisher
  65. Luo X, Jiang X, Li J, Bai Y, Li Z, Wei P, et al. Insulin-like growth factor-1 attenuates oxidative stress-induced hepatocyte premature senescence in liver fibrogenesis via regulating nuclear p53-progerin interaction. Cell Death Dis. 2019;10:451 pubmed publisher
  66. Choi J, Zhong X, McAlpine W, Liao T, Zhang D, Fang B, et al. LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. Science. 2019;364: pubmed publisher
  67. Liu X, Zhao P, Wang X, Wang L, Zhu Y, Song Y, et al. Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells. J Exp Clin Cancer Res. 2019;38:184 pubmed publisher
  68. Kucab J, Zou X, Morganella S, Joel M, Nanda A, Nagy E, et al. A Compendium of Mutational Signatures of Environmental Agents. Cell. 2019;177:821-836.e16 pubmed publisher
  69. Chan E, Shibue T, McFarland J, Gaeta B, Ghandi M, Dumont N, et al. WRN helicase is a synthetic lethal target in microsatellite unstable cancers. Nature. 2019;568:551-556 pubmed publisher
  70. Ao Y, Zhang J, Liu Z, Qian M, Li Y, Wu Z, et al. Lamin A buffers CK2 kinase activity to modulate aging in a progeria mouse model. Sci Adv. 2019;5:eaav5078 pubmed publisher
  71. Pillay N, Tighe A, Nelson L, Littler S, Coulson Gilmer C, Bah N, et al. DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors. Cancer Cell. 2019;35:519-533.e8 pubmed publisher
  72. Zhang X, Qin Q, Dai H, Cai S, Zhou C, Guan J. Emodin protects H9c2 cells from hypoxia-induced injury by up-regulating miR-138 expression. Braz J Med Biol Res. 2019;52:e7994 pubmed publisher
  73. Feng F, Wang Z, Li R, Wu Q, Gu C, Xu Y, et al. Citrus alkaline extracts prevent fibroblast senescence to ameliorate pulmonary fibrosis via activation of COX-2. Biomed Pharmacother. 2019;112:108669 pubmed publisher
  74. Zhao Y, Ding L, Wang D, Ye Z, He Y, Ma L, et al. EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis. EMBO J. 2019;38: pubmed publisher
  75. Gronke K, Hernandez P, Zimmermann J, Klose C, Kofoed Branzk M, Guendel F, et al. Interleukin-22 protects intestinal stem cells against genotoxic stress. Nature. 2019;566:249-253 pubmed publisher
  76. Russell J, Lu W, Okabe H, Abrams M, Oertel M, Poddar M, et al. Hepatocyte-Specific β-Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes. Hepatology. 2019;69:742-759 pubmed publisher
  77. Kim S, Jin H, Seo H, Lee H, Lee Y. Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation. Cell Death Differ. 2019;26:812-825 pubmed publisher
  78. Li M, Yang X, LU X, Dai N, Zhang S, Cheng Y, et al. APE1 deficiency promotes cellular senescence and premature aging features. Nucleic Acids Res. 2018;46:5664-5677 pubmed publisher
  79. Jin L, Lu J, Gao J. Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration. Biosci Rep. 2018;38: pubmed publisher
  80. Lee C, Hsieh T. Wuho/WDR4 deficiency inhibits cell proliferation and induces apoptosis via DNA damage in mouse embryonic fibroblasts. Cell Signal. 2018;47:16-26 pubmed publisher
  81. Galanos P, Pappas G, Polyzos A, Kotsinas A, Svolaki I, Giakoumakis N, et al. Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability. Genome Biol. 2018;19:37 pubmed publisher
  82. Zhao Y, Tan M, Liu X, Xiong X, Sun Y. Inactivation of ribosomal protein S27-like confers radiosensitivity via the Mdm2-p53 and Mdm2-MRN-ATM axes. Cell Death Dis. 2018;9:145 pubmed publisher
  83. Chen K, Dai H, Yuan J, Chen J, Lin L, Zhang W, et al. Optineurin-mediated mitophagy protects renal tubular epithelial cells against accelerated senescence in diabetic nephropathy. Cell Death Dis. 2018;9:105 pubmed publisher
  84. Zhao X, Huang L, Xu W, Chen X, Shen Y, Zeng W, et al. Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling. Oncotarget. 2017;8:70130-70141 pubmed publisher
  85. Nakagawa N, Li J, Yabuno Nakagawa K, Eom T, Cowles M, Mapp T, et al. APC sets the Wnt tone necessary for cerebral cortical progenitor development. Genes Dev. 2017;31:1679-1692 pubmed publisher
  86. Hsu J, Hubbell Engler B, Adelmant G, Huang J, Joyce C, Vazquez F, et al. PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer. Cancer Res. 2017;77:4613-4625 pubmed publisher
  87. Chavali P, Stojic L, Meredith L, Joseph N, Nahorski M, Sanford T, et al. Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication. Science. 2017;357:83-88 pubmed publisher
  88. He D, Ren B, Liu S, Tan L, Cieply K, Tseng G, et al. Oncogenic activity of amplified miniature chromosome maintenance 8 in human malignancies. Oncogene. 2017;36:3629-3639 pubmed publisher
  89. Lee T, Pelletier J. Dependence of p53-deficient cells on the DHX9 DExH-box helicase. Oncotarget. 2017;8:30908-30921 pubmed publisher
  90. Yu G, Zhang T, Jing Y, Bao Q, Tang Q, Zhang Y. miR-519 suppresses nasopharyngeal carcinoma cell proliferation by targeting oncogene URG4/URGCP. Life Sci. 2017;175:47-51 pubmed publisher
  91. Coni S, Mancuso A, Di Magno L, Sdruscia G, Manni S, Serrao S, et al. Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma. Sci Rep. 2017;7:44079 pubmed publisher
  92. Teveroni E, Pellegrino M, Sacconi S, Calandra P, Cascino I, Farioli Vecchioli S, et al. Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity. J Clin Invest. 2017;127:1531-1545 pubmed publisher
  93. Yuan H, Tan B, Gao S. Tenovin-6 impairs autophagy by inhibiting autophagic flux. Cell Death Dis. 2017;8:e2608 pubmed publisher
  94. Li G, Ji T, Chen J, Fu Y, Hou L, Feng Y, et al. CRL4DCAF8 Ubiquitin Ligase Targets Histone H3K79 and Promotes H3K9 Methylation in the Liver. Cell Rep. 2017;18:1499-1511 pubmed publisher
  95. Tormos A, Rius Pérez S, Jorques M, Rada P, Ramírez L, Valverde A, et al. p38α regulates actin cytoskeleton and cytokinesis in hepatocytes during development and aging. PLoS ONE. 2017;12:e0171738 pubmed publisher
  96. Vendetti F, Leibowitz B, Barnes J, Schamus S, Kiesel B, Abberbock S, et al. Pharmacologic ATM but not ATR kinase inhibition abrogates p21-dependent G1 arrest and promotes gastrointestinal syndrome after total body irradiation. Sci Rep. 2017;7:41892 pubmed publisher
  97. Ritschka B, Storer M, Mas A, Heinzmann F, Ortells M, Morton J, et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev. 2017;31:172-183 pubmed publisher
  98. Xiang J, Yang S, Xin N, Gaertig M, Reeves R, Li S, et al. DYRK1A regulates Hap1-Dcaf7/WDR68 binding with implication for delayed growth in Down syndrome. Proc Natl Acad Sci U S A. 2017;114:E1224-E1233 pubmed publisher
  99. Xu J, Zhou W, Yang F, Chen G, Li H, Zhao Y, et al. The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor. Nat Commun. 2017;8:14002 pubmed publisher
  100. Jin X, Wu N, Dai J, Li Q, Xiao X. TXNIP mediates the differential responses of A549 cells to sodium butyrate and sodium 4-phenylbutyrate treatment. Cancer Med. 2017;6:424-438 pubmed publisher
  101. Song X, Narzt M, Nagelreiter I, Hohensinner P, Terlecki Zaniewicz L, Tschachler E, et al. Autophagy deficient keratinocytes display increased DNA damage, senescence and aberrant lipid composition after oxidative stress in vitro and in vivo. Redox Biol. 2017;11:219-230 pubmed publisher
  102. Choiniere J, Wu J, Wang L. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins. Mol Pharmacol. 2017;91:189-196 pubmed publisher
  103. Yu G, Dou Z, Jia Z. 5?bromo?3?(3?hydroxyprop?1?ynyl)?2H?pyran?2?one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways. Mol Med Rep. 2017;15:153-159 pubmed publisher
  104. Kucab J, Hollstein M, Arlt V, Phillips D. Nutlin-3a selects for cells harbouring TP53 mutations. Int J Cancer. 2017;140:877-887 pubmed publisher
  105. Schlierf A, Altmann E, Quancard J, Jefferson A, Assenberg R, Renatus M, et al. Targeted inhibition of the COP9 signalosome for treatment of cancer. Nat Commun. 2016;7:13166 pubmed publisher
  106. Chen P, Qin L, Li G, Tellides G, Simons M. Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGF?)-dependent smooth muscle cell phenotype modulation. Sci Rep. 2016;6:33407 pubmed publisher
  107. Suman S, Kumar S, N GOUEMO P, Datta K. Increased DNA double-strand break was associated with downregulation of repair and upregulation of apoptotic factors in rat hippocampus after alcohol exposure. Alcohol. 2016;54:45-50 pubmed publisher
  108. Bauer M, Joerger A, Fersht A. 2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells. Proc Natl Acad Sci U S A. 2016;113:E5271-80 pubmed publisher
  109. Hoare M, Ito Y, Kang T, Weekes M, Matheson N, Patten D, et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat Cell Biol. 2016;18:979-92 pubmed publisher
  110. Mihailidou C, Panagiotou C, Kiaris H, Kassi E, Moutsatsou P. Crosstalk between C/EBP homologous protein (CHOP) and glucocorticoid receptor in lung cancer. Mol Cell Endocrinol. 2016;436:211-23 pubmed publisher
  111. Marquez Vilendrer S, Thompson K, Lu L, Reisman D. Mechanism of BRG1 silencing in primary cancers. Oncotarget. 2016;7:56153-56169 pubmed publisher
  112. Hauck L, Grothe D, Billia F. p21(CIP1/WAF1)-dependent inhibition of cardiac hypertrophy in response to Angiotensin II involves Akt/Myc and pRb signaling. Peptides. 2016;83:38-48 pubmed publisher
  113. Rada M, Vasileva E, Lezina L, Marouco D, Antonov A, Macip S, et al. Human EHMT2/G9a activates p53 through methylation-independent mechanism. Oncogene. 2017;36:922-932 pubmed publisher
  114. Lu H, Yang X, Tian X, Tang S, Li L, Zhao S, et al. The in vitro and vivo anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) and MG132 on the aggressive phenotypes of gastric cancer cells. Oncotarget. 2016;7:56508-56525 pubmed publisher
  115. Hampp S, Kiessling T, Buechle K, Mansilla S, Thomale J, Rall M, et al. DNA damage tolerance pathway involving DNA polymerase ? and the tumor suppressor p53 regulates DNA replication fork progression. Proc Natl Acad Sci U S A. 2016;113:E4311-9 pubmed publisher
  116. Lefort K, Ostano P, Mello Grand M, Calpini V, Scatolini M, Farsetti A, et al. Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer. Oncotarget. 2016;7:48011-48026 pubmed publisher
  117. Janjanam J, Rao G. Novel role of cortactin in G protein-coupled receptor agonist-induced nuclear export and degradation of p21Cip1. Sci Rep. 2016;6:28687 pubmed publisher
  118. Dutta A, Le Magnen C, Mitrofanova A, Ouyang X, Califano A, Abate Shen C. Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation. Science. 2016;352:1576-80 pubmed publisher
  119. Hendrayani S, Al Harbi B, Al Ansari M, Silva G, Aboussekhra A. The inflammatory/cancer-related IL-6/STAT3/NF-?B positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts. Oncotarget. 2016;7:41974-41985 pubmed publisher
  120. Chesnokova V, Zonis S, Zhou C, Recouvreux M, Ben Shlomo A, Araki T, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113:E3250-9 pubmed publisher
  121. Ho T, Guilbaud G, Blow J, Sale J, Watson C. The KRAB Zinc Finger Protein Roma/Zfp157 Is a Critical Regulator of Cell-Cycle Progression and Genomic Stability. Cell Rep. 2016;15:724-734 pubmed publisher
  122. Avila A, Illing A, Becker F, Maerz L, Morita Y, Philipp M, et al. Xpg limits the expansion of haematopoietic stem and progenitor cells after ionising radiation. Nucleic Acids Res. 2016;44:6252-61 pubmed publisher
  123. Zhuang L, Yang Y, Ma X, Han B, Wang Z, Zhao Q, et al. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis. 2016;7:e2203 pubmed publisher
  124. He D, Xiang J, Li B, Liu H. The dynamic behavior of Ect2 in response to DNA damage. Sci Rep. 2016;6:24504 pubmed publisher
  125. Seidel P, Remus M, Delacher M, Grigaravicius P, Reuss D, Frappart L, et al. Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitis. Oncotarget. 2016;7:23006-18 pubmed publisher
  126. Yosef R, Pilpel N, Tokarsky Amiel R, Biran A, Ovadya Y, Cohen S, et al. Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun. 2016;7:11190 pubmed publisher
  127. Garcia C, Videla Richardson G, Dimopoulos N, Fernandez Espinosa D, Miriuka S, Sevlever G, et al. Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199. PLoS ONE. 2016;11:e0152607 pubmed publisher
  128. Cao C, Wang Z, Huang L, Bai L, Wang Y, Liang Y, et al. Down-regulation of tumor endothelial marker 8 suppresses cell proliferation mediated by ERK1/2 activity. Sci Rep. 2016;6:23419 pubmed publisher
  129. Lee H, Dai F, Zhuang L, Xiao Z, Kim J, Zhang Y, et al. BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21. Oncotarget. 2016;7:19134-46 pubmed publisher
  130. Weeks R, Ludgate J, LeMée G, Morison I. TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells. PLoS ONE. 2016;11:e0151341 pubmed publisher
  131. Barroso González J, Auclair S, Luan S, Thomas L, Atkins K, Aslan J, et al. PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage. Cell Death Differ. 2016;23:1448-57 pubmed publisher
  132. Ardini E, Menichincheri M, Banfi P, Bosotti R, De Ponti C, Pulci R, et al. Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications. Mol Cancer Ther. 2016;15:628-39 pubmed publisher
  133. Liu X, Tan Y, Zhang C, Zhang Y, Zhang L, Ren P, et al. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. EMBO Rep. 2016;17:349-66 pubmed publisher
  134. Xie X, Lozano G, Siddik Z. Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53. Oncogene. 2016;35:4798-806 pubmed publisher
  135. Niopek D, Wehler P, Roensch J, Eils R, Di Ventura B. Optogenetic control of nuclear protein export. Nat Commun. 2016;7:10624 pubmed publisher
  136. Le Trilling V, Megger D, Katschinski B, Landsberg C, Rückborn M, Tao S, et al. Broad and potent antiviral activity of the NAE inhibitor MLN4924. Sci Rep. 2016;6:19977 pubmed publisher
  137. Nassour J, Martien S, Martin N, Deruy E, Tomellini E, Malaquin N, et al. Defective DNA single-strand break repair is responsible for senescence and neoplastic escape of epithelial cells. Nat Commun. 2016;7:10399 pubmed publisher
  138. Qiu L, Wu J, Pan C, Tan X, Lin J, Liu R, et al. Downregulation of CDC27 inhibits the proliferation of colorectal cancer cells via the accumulation of p21Cip1/Waf1. Cell Death Dis. 2016;7:e2074 pubmed publisher
  139. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  140. Cousin F, Jouan Lanhouet S, Théret N, Brenner C, Jouan E, Le Moigne Muller G, et al. The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer. Oncotarget. 2016;7:7161-78 pubmed publisher
  141. Wu B, Chen H, Cai C, Fang J, Wu C, Huang L, et al. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686. Oncotarget. 2016;7:6847-63 pubmed publisher
  142. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  143. Kucab J, Zwart E, van Steeg H, Luijten M, Schmeiser H, Phillips D, et al. TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts. DNA Repair (Amst). 2016;39:21-33 pubmed publisher
  144. Marazita M, Dugour A, Marquioni Ramella M, Figueroa J, Suburo A. Oxidative stress-induced premature senescence dysregulates VEGF and CFH expression in retinal pigment epithelial cells: Implications for Age-related Macular Degeneration. Redox Biol. 2016;7:78-87 pubmed publisher
  145. Kondo H, Kim H, Wang L, Okada M, Paul C, Millard R, et al. Blockade of senescence-associated microRNA-195 in aged skeletal muscle cells facilitates reprogramming to produce induced pluripotent stem cells. Aging Cell. 2016;15:56-66 pubmed publisher
  146. Suvorova I, Grigorash B, Chuykin I, Pospelova T, Pospelov V. G1 checkpoint is compromised in mouse ESCs due to functional uncoupling of p53-p21Waf1 signaling. Cell Cycle. 2016;15:52-63 pubmed publisher
  147. Mehraein Ghomi F, Church D, Schreiber C, Weichmann A, Basu H, Wilding G. Inhibitor of p52 NF-κB subunit and androgen receptor (AR) interaction reduces growth of human prostate cancer cells by abrogating nuclear translocation of p52 and phosphorylated AR(ser81). Genes Cancer. 2015;6:428-44 pubmed
  148. Huang Y, Chen N, Miao D. Biological effects of pyrroloquinoline quinone on liver damage in Bmi-1 knockout mice. Exp Ther Med. 2015;10:451-458 pubmed
  149. Martín Pardillos A, Sorribas V. Effects of donor age and proliferative aging on the phenotype stability of rat aortic smooth muscle cells. Physiol Rep. 2015;3: pubmed publisher
  150. Dewaele M, Tabaglio T, Willekens K, Bezzi M, Teo S, Low D, et al. Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth. J Clin Invest. 2016;126:68-84 pubmed publisher
  151. Kraut B, Maier H, Kókai E, Fiedler K, Boettger T, Illing A, et al. Cardiac-Specific Activation of IKK2 Leads to Defects in Heart Development and Embryonic Lethality. PLoS ONE. 2015;10:e0141591 pubmed publisher
  152. Bauer J, Ozden O, Akagi N, Carroll T, Principe D, Staudacher J, et al. Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer. Mol Cancer. 2015;14:182 pubmed publisher
  153. Felli N, Errico M, Pedini F, Petrini M, Puglisi R, Bellenghi M, et al. AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression. Oncogene. 2016;35:3016-26 pubmed publisher
  154. Hu D, Gur M, Zhou Z, Gamper A, Hung M, Fujita N, et al. Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis. Nat Commun. 2015;6:8419 pubmed publisher
  155. Daou S, Hammond Martel I, Mashtalir N, Barbour H, Gagnon J, Iannantuono N, et al. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer. J Biol Chem. 2015;290:28643-63 pubmed publisher
  156. Anderson K, Russell A, Foletta V. NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide - But not palmitate-induced toxicity. FEBS Open Bio. 2015;5:668-81 pubmed publisher
  157. Lee N, Kwon J, Kim Y, Kim S, Park S, Xu W, et al. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition. Oncotarget. 2015;6:30130-48 pubmed publisher
  158. Wang J, Hua W, Huang S, Fan K, Takeshima L, Mao Y, et al. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb. Oncotarget. 2015;6:30165-77 pubmed publisher
  159. Mansara P, Deshpande R, Vaidya M, Kaul Ghanekar R. Differential Ratios of Omega Fatty Acids (AA/EPA+DHA) Modulate Growth, Lipid Peroxidation and Expression of Tumor Regulatory MARBPs in Breast Cancer Cell Lines MCF7 and MDA-MB-231. PLoS ONE. 2015;10:e0136542 pubmed publisher
  160. Zhang X, Wang X, Wu T, Li B, Liu T, Wang R, et al. Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation. Sci Rep. 2015;5:12579 pubmed publisher
  161. Succoio M, Comegna M, D Ambrosio C, Scaloni A, Cimino F, Faraonio R. Proteomic analysis reveals novel common genes modulated in both replicative and stress-induced senescence. J Proteomics. 2015;128:18-29 pubmed publisher
  162. Deben C, Wouters A, Op de Beeck K, Van den Bossche J, Jacobs J, Zwaenepoel K, et al. The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer. Oncotarget. 2015;6:22666-79 pubmed
  163. Trokovic R, Weltner J, Noisa P, Raivio T, Otonkoski T. Combined negative effect of donor age and time in culture on the reprogramming efficiency into induced pluripotent stem cells. Stem Cell Res. 2015;15:254-62 pubmed publisher
  164. Galoian K, Qureshi A, D Ippolito G, Schiller P, Molinari M, Johnstone A, et al. Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1. Int J Oncol. 2015;47:465-72 pubmed publisher
  165. Rueda Rincon N, Bloch K, Derua R, Vyas R, Harms A, Hankemeier T, et al. p53 attenuates AKT signaling by modulating membrane phospholipid composition. Oncotarget. 2015;6:21240-54 pubmed
  166. Xie C, Wei D, Zhao L, Marchetto S, Mei L, Borg J, et al. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis. J Cell Biol. 2015;209:721-37 pubmed publisher
  167. Kotipatruni R, Ren X, Thotala D, Jaboin J. NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells. Oncotarget. 2015;6:17594-604 pubmed
  168. Cheedipudi S, Puri D, Saleh A, Gala H, Rumman M, Pillai M, et al. A fine balance: epigenetic control of cellular quiescence by the tumor suppressor PRDM2/RIZ at a bivalent domain in the cyclin a gene. Nucleic Acids Res. 2015;43:6236-56 pubmed publisher
  169. Moiseeva O, Lessard F, Acevedo Aquino M, Vernier M, Tsantrizos Y, Ferbeyre G. Mutant lamin A links prophase to a p53 independent senescence program. Cell Cycle. 2015;14:2408-21 pubmed publisher
  170. Scala F, Brighenti E, Govoni M, Imbrogno E, Fornari F, Treré D, et al. Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate. Oncogene. 2016;35:977-89 pubmed publisher
  171. Ahronian L, Driscoll D, Klimstra D, Lewis B. The p53R172H mutant does not enhance hepatocellular carcinoma development and progression. PLoS ONE. 2015;10:e0123816 pubmed publisher
  172. Chen P, Wu T, Cheng Y, Chen C, Lee H. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation. Oncotarget. 2015;6:14274-89 pubmed
  173. Scialpi F, Mellis D, Ditzel M. EDD, a ubiquitin-protein ligase of the N-end rule pathway, associates with spindle assembly checkpoint components and regulates the mitotic response to nocodazole. J Biol Chem. 2015;290:12585-94 pubmed publisher
  174. Beier J, Jokinen J, Holz G, Whang P, Martin A, Warner N, et al. Novel mechanism of arenavirus-induced liver pathology. PLoS ONE. 2015;10:e0122839 pubmed publisher
  175. Meena J, Cerutti A, Beichler C, Morita Y, Bruhn C, Kumar M, et al. Telomerase abrogates aneuploidy-induced telomere replication stress, senescence and cell depletion. EMBO J. 2015;34:1371-84 pubmed publisher
  176. Kirschner K, Samarajiwa S, Cairns J, Menon S, Perez Mancera P, Tomimatsu K, et al. Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53. PLoS Genet. 2015;11:e1005053 pubmed publisher
  177. Albers J, Danzer C, Rechsteiner M, Lehmann H, Brandt L, Hejhal T, et al. A versatile modular vector system for rapid combinatorial mammalian genetics. J Clin Invest. 2015;125:1603-19 pubmed publisher
  178. Gergics P, Brinkmeier M, Camper S. Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia. Mol Endocrinol. 2015;29:597-612 pubmed publisher
  179. Chen Y, Terajima M, Yang Y, Sun L, Ahn Y, Panková D, et al. Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma. J Clin Invest. 2015;125:1147-62 pubmed publisher
  180. Guerrero A, Iglesias C, Raguz S, Floridia E, Gil J, Pombo C, et al. The cerebral cavernous malformation 3 gene is necessary for senescence induction. Aging Cell. 2015;14:274-83 pubmed publisher
  181. Rao R, Dhele N, Cheemadan S, Ketkar A, Jayandharan G, Palakodeti D, et al. Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming. Sci Rep. 2015;5:8229 pubmed publisher
  182. Iglesias Gato D, Chuan Y, Jiang N, Svensson C, Bao J, Paul I, et al. OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo. Mol Cancer. 2015;14:8 pubmed publisher
  183. Cai K, Wang Y, Smith E, Smedberg J, Yang D, Yang W, et al. Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice. Neoplasia. 2015;17:89-100 pubmed publisher
  184. Raouf S, Weston C, Yucel N. Registered report: senescence surveillance of pre-malignant hepatocytes limits liver cancer development. elife. 2015;4: pubmed publisher
  185. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed publisher
  186. Myklebust L, Van Damme P, Støve S, Dörfel M, Abboud A, Kalvik T, et al. Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects. Hum Mol Genet. 2015;24:1956-76 pubmed publisher
  187. Wei Z, Guo H, Liu Z, Zhang X, Liu Q, Qian Y, et al. CUL4B impedes stress-induced cellular senescence by dampening a p53-reactive oxygen species positive feedback loop. Free Radic Biol Med. 2015;79:1-13 pubmed publisher
  188. Kim T, Kim H, Kang Y, Yoon S, Lee J, Choi W, et al. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts. Biochim Biophys Acta. 2015;1850:401-10 pubmed publisher
  189. Peterson E, Menon V, Gatti L, Kipping R, Dewasinghe D, Perego P, et al. Nucleolar targeting by platinum: p53-independent apoptosis follows rRNA inhibition, cell-cycle arrest, and DNA compaction. Mol Pharm. 2015;12:287-97 pubmed publisher
  190. Bongers K, Fox D, Kunkel S, Stebounova L, Murry D, Pufall M, et al. Spermine oxidase maintains basal skeletal muscle gene expression and fiber size and is strongly repressed by conditions that cause skeletal muscle atrophy. Am J Physiol Endocrinol Metab. 2015;308:E144-58 pubmed publisher
  191. Wohak L, Krais A, Kucab J, Stertmann J, Øvrebø S, Seidel A, et al. Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism. Arch Toxicol. 2016;90:291-304 pubmed publisher
  192. Chen J, Shin J, Zhao R, Phan L, Wang H, Xue Y, et al. CSN6 drives carcinogenesis by positively regulating Myc stability. Nat Commun. 2014;5:5384 pubmed publisher
  193. Liu X, Yang W, Zheng P. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas. Oncotarget. 2014;5:10870-85 pubmed
  194. Xu H, Zhou Y, Coughlan K, Ding Y, Wang S, Wu Y, et al. AMPKα1 deficiency promotes cellular proliferation and DNA damage via p21 reduction in mouse embryonic fibroblasts. Biochim Biophys Acta. 2015;1853:65-73 pubmed publisher
  195. Wang T, Guo S, Liu Z, Wu L, Li M, Yang J, et al. CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling. Oncotarget. 2014;5:10293-306 pubmed
  196. Brun C, Périé L, Baraige F, Vernus B, Bonnieu A, Blanquet V. Absence of hyperplasia in Gasp-1 overexpressing mice is dependent on myostatin up-regulation. Cell Physiol Biochem. 2014;34:1241-59 pubmed publisher
  197. Patwardhan G, Hosain S, Liu D, Khiste S, Zhao Y, Bielawski J, et al. Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells. Biochim Biophys Acta. 2014;1841:1571-80 pubmed publisher
  198. Jacob A, Singh R, Comiskey D, Rouhier M, Mohammad F, Bebee T, et al. Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways. PLoS ONE. 2014;9:e104444 pubmed publisher
  199. Vassilopoulos A, Tominaga Y, Kim H, Lahusen T, Li B, Yu H, et al. WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis. Oncogene. 2015;34:3023-35 pubmed publisher
  200. Hamilton G, Abraham A, Morton J, Sampson O, Pefani D, Khoronenkova S, et al. AKT regulates NPM dependent ARF localization and p53mut stability in tumors. Oncotarget. 2014;5:6142-67 pubmed
  201. Mungamuri S, Wang S, Manfredi J, Gu W, Aaronson S. Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters. Oncogene. 2015;34:2461-70 pubmed publisher
  202. Patel A, Burton D, Halvorsen K, Balkan W, Reiner T, Perez Stable C, et al. MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways. Oncogene. 2015;34:2586-96 pubmed publisher
  203. Yamauchi T, Nishiyama M, Moroishi T, Yumimoto K, Nakayama K. MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24. Mol Cell Biol. 2014;34:3321-40 pubmed publisher
  204. Tabor V, Bocci M, Alikhani N, Kuiper R, Larsson L. MYC synergizes with activated BRAFV600E in mouse lung tumor development by suppressing senescence. Cancer Res. 2014;74:4222-9 pubmed publisher
  205. Otani K, Dong Y, Li X, Lu J, Zhang N, Xu L, et al. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer. J Pathol. 2014;234:302-15 pubmed publisher
  206. Kaneko Y, Ota A, Nakashima A, Nagasaki H, Kodani Y, Mori K, et al. Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G? phase and protects them from UV light-induced apoptosis. J Neural Transm (Vienna). 2015;122:187-99 pubmed publisher
  207. Hayashi A, Suenaga N, Shiomi Y, Nishitani H. PCNA-dependent ubiquitination of Cdt1 and p21 in mammalian cells. Methods Mol Biol. 2014;1170:367-82 pubmed publisher
  208. Ying Y, Kim J, Westphal S, Long K, Padanilam B. Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury. J Am Soc Nephrol. 2014;25:2707-16 pubmed publisher
  209. Lu H, Fang E, Sykora P, Kulikowicz T, Zhang Y, Becker K, et al. Senescence induced by RECQL4 dysfunction contributes to Rothmund-Thomson syndrome features in mice. Cell Death Dis. 2014;5:e1226 pubmed publisher
  210. Machado Neto J, Lazarini M, Favaro P, Franchi G, Nowill A, Saad S, et al. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells. Exp Cell Res. 2014;324:137-45 pubmed publisher
  211. Cheng J, Fan Y, Xu X, Dou J, Tang Y, Zhong X, et al. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways. Cell Death Dis. 2014;5:e1079 pubmed publisher
  212. Okada N, Lin C, Ribeiro M, Biton A, Lai G, He X, et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev. 2014;28:438-50 pubmed publisher
  213. Berkenkamp B, Susnik N, Baisantry A, Kuznetsova I, Jacobi C, Sörensen Zender I, et al. In vivo and in vitro analysis of age-associated changes and somatic cellular senescence in renal epithelial cells. PLoS ONE. 2014;9:e88071 pubmed publisher
  214. Borkham Kamphorst E, Schaffrath C, Van De Leur E, Haas U, Tihaa L, Meurer S, et al. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-? signaling. Biochim Biophys Acta. 2014;1843:902-14 pubmed publisher
  215. Aoshiba K, Tsuji T, Itoh M, Semba S, Yamaguchi K, Nakamura H, et al. A murine model of airway fibrosis induced by repeated naphthalene exposure. Exp Toxicol Pathol. 2014;66:169-77 pubmed publisher
  216. Jackson D, Li H, Mitchell K, Joshi A, Elferink C. Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression. Mol Pharmacol. 2014;85:533-41 pubmed publisher
  217. Bots M, Verbrugge I, Martin B, Salmon J, Ghisi M, Baker A, et al. Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors. Blood. 2014;123:1341-52 pubmed publisher
  218. Pospelova T, Bykova T, Zubova S, Katolikova N, Yartzeva N, Pospelov V. Rapamycin induces pluripotent genes associated with avoidance of replicative senescence. Cell Cycle. 2013;12:3841-51 pubmed publisher
  219. Aoshiba K, Tsuji T, Kameyama S, Itoh M, Semba S, Yamaguchi K, et al. Senescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury. Exp Toxicol Pathol. 2013;65:1053-62 pubmed publisher
  220. Brochier C, Dennis G, Rivieccio M, McLaughlin K, Coppola G, Ratan R, et al. Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons. J Neurosci. 2013;33:8621-32 pubmed publisher
  221. Jelinek M, Balusikova K, Kopperová D, Němcová Fürstová V, Srámek J, Fidlerova J, et al. Caspase-2 is involved in cell death induction by taxanes in breast cancer cells. Cancer Cell Int. 2013;13:42 pubmed publisher
  222. Parsons M, McCormick L, Janke L, Howard A, Bouchier Hayes L, Green D. Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice. Cell Death Differ. 2013;20:1174-82 pubmed publisher
  223. Kuchenreuther M, Weber J. The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation. Oncogene. 2014;33:300-7 pubmed publisher
  224. Kohn E, Yang Y, Du Z, Nagano Y, Van Schyndle C, Herrmann M, et al. Biological responses to TGF-β in the mammary epithelium show a complex dependency on Smad3 gene dosage with important implications for tumor progression. Mol Cancer Res. 2012;10:1389-99 pubmed publisher
  225. Diril M, Ratnacaram C, Padmakumar V, Du T, Wasser M, Coppola V, et al. Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. Proc Natl Acad Sci U S A. 2012;109:3826-31 pubmed publisher
  226. Romanov V, Bardin A, Zubova S, Bykova T, Pospelov V, Pospelova T. p21Waf1 is required for complete oncogenic transformation of mouse embryo fibroblasts by E1Aad5 and c-Ha-ras oncogenes. Biochimie. 2011;93:1408-14 pubmed publisher
  227. Pinho A, Rooman I, Real F. p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells. Cell Cycle. 2011;10:1312-21 pubmed
  228. Yang G, Chang B, Yang F, Guo X, Cai K, Xiao X, et al. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res. 2010;16:3171-81 pubmed publisher
  229. Siatecka M, Lohmann F, Bao S, Bieker J. EKLF directly activates the p21WAF1/CIP1 gene by proximal promoter and novel intronic regulatory regions during erythroid differentiation. Mol Cell Biol. 2010;30:2811-22 pubmed publisher
  230. Strauss G, Westhoff M, Fischer Posovszky P, Fulda S, Schanbacher M, Eckhoff S, et al. 4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG. Cell Death Differ. 2008;15:332-43 pubmed
  231. Meng L, Kohn K, Pommier Y. Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288). Oncogene. 2007;26:4806-16 pubmed
  232. Chen J, Ozanne S. Deep senescent human fibroblasts show diminished DNA damage foci but retain checkpoint capacity to oxidative stress. FEBS Lett. 2006;580:6669-73 pubmed